V(D)J recombination constructs the variable regions of immunoglobulin and T cell receptor genes in developing lymphocytes through assembly of component gene fragments. The array of possible combinations for gene assembly is the primary basis for sequence diversity of the antigen binding receptor molecules in the immune system. Aberrant recombination reactions, such as those resulting in chromosomal translocations, can lead to lymphoid malignancies. In addition, reduced V(D)J recombination activity, as a result of point mutations in one or the other RAG protein, can lead to immunodeficiency diseases. To understand the molecular basis for these diseases, the factors that catalyze the V(D)J recombination reaction need to be better characterized. The initial site-specific DNA cleavage reaction is catalyzed by the V(D)J recombinase consisting of RAG1 and RAG2, proteins encoded by the recombination-activating genes. Together the RAG proteins bind to a conserved recombination signal sequence (RSS), which borders each gene fragment, and catalyzes double-stranded cleavage between the RSS and the bordering gene fragment in a two-step mechanism. The joining steps, resulting in assembly of the gene fragments, require additional ubiquitous factors including proteins that function in double-stranded DNA break repair. The broad objective of this proposal is to characterize the macromolecular assembly of the RAG proteins with the RSS. In our recent studies, we have identified structural domains of RAG1 that each either interacts with RAG2, the RSS, or the coding gene segments. Based on our results, we have developed a model for participation of the RAG1 DNA-binding domains at each step of the V(D)J recombination reaction. To test our model, we will further characterize the DNA-binding domains in RAG1, and determine their importance at each catalytic step in the recombination reaction. In addition, we will investigate potential regulatory roles for RAG2 in facilitating the association of RAG1 with the RSS. Finally, the requirement for participation of each RAG1 domain in the formation of the catalytically-active complex, as well as in DNA cleavage activity, will be tested. Results from these studies will provide a valuable framework in the determination of the assembly and mechanism of the V(D)J recombinase.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI054467-01
Application #
6598774
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Kirkham, Perry M
Project Start
2003-09-15
Project End
2007-12-31
Budget Start
2003-09-15
Budget End
2003-12-31
Support Year
1
Fiscal Year
2003
Total Cost
$84,683
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Biochemistry
Type
Schools of Medicine
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Matveev, Alexander V; Fitzgerald, J Browning; Xu, Jianhua et al. (2010) The disease-causing mutations in the carboxyl terminus of the cone cyclic nucleotide-gated channel CNGA3 subunit alter the local secondary structure and interfere with the channel active conformational change. Biochemistry 49:1628-39
Zhao, Shuying; Gwyn, Lori M; De, Pallabi et al. (2009) A non-sequence-specific DNA binding mode of RAG1 is inhibited by RAG2. J Mol Biol 387:744-58
Gwyn, Lori M; Peak, Mandy M; De, Pallabi et al. (2009) A zinc site in the C-terminal domain of RAG1 is essential for DNA cleavage activity. J Mol Biol 390:863-78
De, Pallabi; Zhao, Shuying; Gwyn, Lori M et al. (2008) Thermal dependency of RAG1 self-association properties. BMC Biochem 9:5
De, Pallabi; Rodgers, Karla K (2004) Putting the pieces together: identification and characterization of structural domains in the V(D)J recombination protein RAG1. Immunol Rev 200:70-82
De, Pallabi; Peak, Mandy M; Rodgers, Karla K (2004) DNA cleavage activity of the V(D)J recombination protein RAG1 is autoregulated. Mol Cell Biol 24:6850-60